The pharmaceutical industry lobby is challenging a recently passed Washington state law that regulates how drugmakers contract with pharmacies in the state.
The Pharmaceutical Research and Manufacturers of America (PhRMA) filed a lawsuit Friday in the US District Court for the Western District of Washington, alleging the state’s S.B. 5981, which prohibits manufacturers from imposing limitations on a pharmacy’s participation in the federal 340B drug discount program, violates the supremacy clause of the US Constitution.
Under the federal 340B program, drugmakers are required to discount drugs for covered entities, such as qualifying hospitals and clinics, that treat a disproportionate number ...